News Focus
News Focus
icon url

jondoeuk

06/03/22 9:02 PM

#124 RE: jondoeuk #122

Ultimately, the company aims to move to iPSC-derived CAR-T cells as well, but its effort in this area is still at an early stage https://www.nature.com/articles/d41587-021-00027-1

They are also working on iPSC-derived CAR-NK cell therapies as well.